- CEO
- David J. Rosa
- Full Time Employees
- 17,021
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- Sunnyvale CA United States of America
- IPO Date
- Dec 22, 2025
- Business
- Intuitive Surgical, Inc. develops, manufactures, and markets robotic-assisted surgical systems and minimally invasive care solutions for hospitals and physicians worldwide. Founded in 1995 and headquartered in Sunnyvale, California, the company’s core offerings include the da Vinci surgical platform, including multiport and single-port systems such as da Vinci 5; the Ion endoluminal system for minimally invasive lung biopsy; procedure-specific instruments and accessories; staplers and endoscopic devices; vision and imaging technologies; software and digital workflow tools; and training, service, and support for its installed base. Intuitive serves healthcare providers across the United States and international markets, with clinical use spanning specialties such as urology, gynecology, thoracic surgery, general surgery, and colorectal surgery. In March 2026, the company expanded its European operations by acquiring its distributors in Italy, Spain, and Portugal, establishing direct operations in those markets and adding approximately 250 employees. During 2025, Intuitive obtained FDA clearance for Ion software updates that incorporate artificial intelligence across the navigation workflow and enhance imaging capabilities, cleared SP SureForm 45 staplers for use with the da Vinci SP system in the United States and selected Asian markets, and continued the rollout of da Vinci 5, with system placements and procedure volumes rising materially; full-year 2025 worldwide procedures increased 19%, driven by 18% growth in da Vinci procedures and 51% growth in Ion procedures.